Pennant Investors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-146,100
Closed -$479K 29
2024
Q2
$479K Hold
146,100
0.13% 21
2024
Q1
$1.07M Hold
146,100
0.27% 14
2023
Q4
$546K Buy
+146,100
New +$546K 0.12% 15